Total words: 3068 | 2-word phrases: 780 | 3-word phrases: 919 | 4-word phrases: 993
PAGE INFO
Title | Try to keep the title under 60 characters (0 characters) |
Description | Try to keep the meta description between 50 - 160 characters (45 characters) Copay cards for patients. HCP for physicians. |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | H1 tag on the page (39 characters) Welcome to the Stemline Savings Program |
ONE WORD PHRASES 376 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | your | | | | | | | 46 | 12.23% |
2 | to | | | | | | | 35 | 9.31% |
3 | you | | | | | | | 31 | 8.24% |
4 | and | | | | | | | 29 | 7.71% |
5 | or | | | | | | | 29 | 7.71% |
6 | of | | | | | | | 24 | 6.38% |
7 | the | | | | | | | 23 | 6.12% |
8 | orserdu | | | | | | | 23 | 6.12% |
9 | elzonris | | | | | | | 22 | 5.85% |
10 | is | | | | | | | 18 | 4.79% |
TWO WORD PHRASES 780 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | healthcare provider | | | | | | | 18 | 2.31% |
2 | your healthcare | | | | | | | 16 | 2.05% |
3 | side effects | | | | | | | 13 | 1.67% |
4 | if you | | | | | | | 11 | 1.41% |
5 | of the | | | | | | | 9 | 1.15% |
6 | treatment with | | | | | | | 9 | 1.15% |
7 | is a | | | | | | | 8 | 1.03% |
8 | become pregnant | | | | | | | 7 | 0.90% |
9 | with orserdu | | | | | | | 7 | 0.90% |
10 | important safety | | | | | | | 6 | 0.77% |
11 | is not | | | | | | | 5 | 0.64% |
12 | prescription medicine | | | | | | | 5 | 0.64% |
13 | provider will | | | | | | | 5 | 0.64% |
14 | in your | | | | | | | 5 | 0.64% |
15 | during treatment | | | | | | | 5 | 0.64% |
16 | tell your | | | | | | | 5 | 0.64% |
17 | to your | | | | | | | 5 | 0.64% |
18 | the last | | | | | | | 4 | 0.51% |
19 | to become | | | | | | | 4 | 0.51% |
20 | to treat | | | | | | | 4 | 0.51% |
THREE WORD PHRASES 919 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | your healthcare provider | | | | | | | 16 | 1.74% |
2 | treatment with orserdu | | | | | | | 6 | 0.65% |
3 | healthcare provider will | | | | | | | 5 | 0.54% |
4 | during treatment with | | | | | | | 5 | 0.54% |
5 | to become pregnant | | | | | | | 4 | 0.44% |
6 | capillary leak syndrome | | | | | | | 4 | 0.44% |
7 | or plan to | | | | | | | 4 | 0.44% |
8 | and for 1 | | | | | | | 4 | 0.44% |
9 | elzonris can cause | | | | | | | 4 | 0.44% |
10 | tell your healthcare | | | | | | | 4 | 0.44% |
11 | for 1 week | | | | | | | 4 | 0.44% |
12 | 1 week after | | | | | | | 4 | 0.44% |
13 | the last dose | | | | | | | 4 | 0.44% |
14 | it is not | | | | | | | 4 | 0.44% |
15 | week after the | | | | | | | 3 | 0.33% |
16 | who are able | | | | | | | 3 | 0.33% |
17 | after the last | | | | | | | 3 | 0.33% |
18 | last dose tell | | | | | | | 3 | 0.33% |
19 | dose tell your | | | | | | | 3 | 0.33% |
20 | side effects of | | | | | | | 3 | 0.33% |
21 | you should use | | | | | | | 3 | 0.33% |
22 | immediately if you | | | | | | | 3 | 0.33% |
23 | medicines you take | | | | | | | 3 | 0.33% |
24 | the medicines you | | | | | | | 3 | 0.33% |
25 | treatment with elzonris | | | | | | | 3 | 0.33% |
26 | are able to | | | | | | | 3 | 0.33% |
27 | if you develop | | | | | | | 3 | 0.33% |
28 | is a prescription | | | | | | | 3 | 0.33% |
29 | become pregnant you | | | | | | | 3 | 0.33% |
30 | levels in your | | | | | | | 3 | 0.33% |
FOUR WORD PHRASES 993 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | for 1 week after | | | | | | | 4 | 0.40% |
2 | and for 1 week | | | | | | | 4 | 0.40% |
3 | tell your healthcare provider | | | | | | | 4 | 0.40% |
4 | 1 week after the | | | | | | | 3 | 0.30% |
5 | week after the last | | | | | | | 3 | 0.30% |
6 | after the last dose | | | | | | | 3 | 0.30% |
7 | the last dose tell | | | | | | | 3 | 0.30% |
8 | last dose tell your | | | | | | | 3 | 0.30% |
9 | dose tell your healthcare | | | | | | | 3 | 0.30% |
10 | is a prescription medicine | | | | | | | 3 | 0.30% |
11 | the medicines you take | | | | | | | 3 | 0.30% |
12 | levels in your blood | | | | | | | 3 | 0.30% |
13 | serious side effects including | | | | | | | 3 | 0.30% |
14 | cause serious side effects | | | | | | | 3 | 0.30% |
15 | is not known if | | | | | | | 3 | 0.30% |
16 | it is not known | | | | | | | 3 | 0.30% |
17 | during treatment with orserdu | | | | | | | 3 | 0.30% |
18 | your healthcare provider will | | | | | | | 3 | 0.30% |
19 | who are able to | | | | | | | 3 | 0.30% |
20 | a test to make | | | | | | | 2 | 0.20% |
21 | for you it is | | | | | | | 2 | 0.20% |
22 | make sure that orserdu | | | | | | | 2 | 0.20% |
23 | sure that orserdu is | | | | | | | 2 | 0.20% |
24 | your body’s tissues this | | | | | | | 2 | 0.20% |
25 | if you have any | | | | | | | 2 | 0.20% |
26 | body’s tissues this is | | | | | | | 2 | 0.20% |
27 | right for you it | | | | | | | 2 | 0.20% |
28 | not known if orserdu | | | | | | | 2 | 0.20% |
29 | test to make sure | | | | | | | 2 | 0.20% |
30 | known if orserdu is | | | | | | | 2 | 0.20% |
31 | if orserdu is safe | | | | | | | 2 | 0.20% |
32 | orserdu is safe and | | | | | | | 2 | 0.20% |
33 | is safe and effective | | | | | | | 2 | 0.20% |
34 | safe and effective in | | | | | | | 2 | 0.20% |
35 | tissues this is called | | | | | | | 2 | 0.20% |
36 | contact your healthcare provider | | | | | | | 2 | 0.20% |
37 | to make sure that | | | | | | | 2 | 0.20% |
38 | perform a test to | | | | | | | 2 | 0.20% |
39 | leak syndrome” cls can | | | | | | | 2 | 0.20% |
40 | fluid to leak from | | | | | | | 2 | 0.20% |
EXTERNAL LINKS